RENASANT ($RNST) posted quarterly earnings results on Tuesday, July 22nd. The company reported earnings of $0.69 per share, beating estimates of $0.64 by $0.05. The company also reported revenue of $267,190,000, missing estimates of $269,247,360 by $-2,057,360.
You can see Quiver Quantitative's $RNST stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
RENASANT Insider Trading Activity
RENASANT insiders have traded $RNST stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $RNST stock by insiders over the last 6 months:
- KELLY HUTCHESON (EVP/Chief Accounting Officer) sold 1,310 shares for an estimated $48,103
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
RENASANT Hedge Fund Activity
We have seen 134 institutional investors add shares of RENASANT stock to their portfolio, and 84 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 1,582,105 shares (+22.0%) to their portfolio in Q1 2025, for an estimated $53,680,822
- MACQUARIE GROUP LTD added 1,120,950 shares (+119.7%) to their portfolio in Q1 2025, for an estimated $38,033,833
- WELLINGTON MANAGEMENT GROUP LLP added 1,112,946 shares (+232.8%) to their portfolio in Q1 2025, for an estimated $37,762,257
- MILLENNIUM MANAGEMENT LLC removed 445,265 shares (-71.7%) from their portfolio in Q1 2025, for an estimated $15,107,841
- MORGAN STANLEY added 435,070 shares (+68.8%) to their portfolio in Q1 2025, for an estimated $14,761,925
- JENNISON ASSOCIATES LLC added 393,319 shares (+33.5%) to their portfolio in Q1 2025, for an estimated $13,345,313
- MARSHALL WACE, LLP removed 369,356 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $12,532,249
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
RENASANT Analyst Ratings
Wall Street analysts have issued reports on $RNST in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 05/06/2025
- Raymond James issued a "Strong Buy" rating on 04/24/2025
- Stephens & Co. issued a "Overweight" rating on 01/30/2025
- Piper Sandler issued a "Overweight" rating on 01/30/2025
To track analyst ratings and price targets for RENASANT, check out Quiver Quantitative's $RNST forecast page.
RENASANT Price Targets
Multiple analysts have issued price targets for $RNST recently. We have seen 4 analysts offer price targets for $RNST in the last 6 months, with a median target of $43.5.
Here are some recent targets:
- Catherine Mealor from Keefe, Bruyette & Woods set a target price of $43.0 on 05/06/2025
- Michael Rose from Raymond James set a target price of $40.0 on 04/24/2025
- Matt Olney from Stephens & Co. set a target price of $47.0 on 01/30/2025
- Stephen Scouten from Piper Sandler set a target price of $44.0 on 01/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
